Format

Send to

Choose Destination
Chembiochem. 2017 Feb 16;18(4):374-377. doi: 10.1002/cbic.201600592. Epub 2017 Jan 18.

Natural Product Kuwanon-L Inhibits HIV-1 Replication through Multiple Target Binding.

Author information

1
Department of Biotechnology, Chemistry and Pharmacy, University of Siena, Via Aldo Moro 2, 53100, Siena, Italy.
2
Department of Life and Environmental Sciences, University of Cagliari, Cittadella Universitaria di Monserrato, SS 554, 09042, Monserrato, Cagliari, Italy.
3
Laboratory of Microbiology, San Raffaele Hospital, IRCCS, Via Olgettina 58, 20132, Milan, Italy.
4
Department of Biotechnology and Life Sciences, University of Insubria, Via Ravasi 2, 21100, Varese, Italy.
5
Department of Chemistry and Technology of Drugs, University of Rome "Sapienza", Piazzale Aldo Moro 5, 00185, Roma, Italy.
6
Lead Discovery Siena s.r.l., Via Vittorio Alfieri 31, 53019, Castelnuovo Berardenga, Italy.

Abstract

In recent years many advances have been made in the fight against HIV-1 infection. However, the lack of a vaccine, together with the increasing resistance to the highly active anti-retroviral therapy (HAART), make HIV-1 infection still a serious global emergency. Thus, new compounds with original modes of action are continuously required, and natural products have ever been a very interesting class of pharmacologically active molecules. Some of them have been used since ancient times against viral infections. Here we present a work in which we suggest that kuwanon-L, a natural product active as an HIV-1 integrase (IN) inhibitor, might exert its overall antiviral activity through binding to multiple viral targets. Specific enzymatic tests, together with a time-of-addition (TOA) experiment, support our hypothesis of binding both to IN and to reverse transcriptase (RT). Overall, this compound can be considered an attractive lead for the development of new classes of antiviral agents able to overcome the problem of resistance, due to its ability to exert its action by binding simultaneously to multiple viral targets.

KEYWORDS:

HIV-1 RNase H; antiviral agents; inhibitors; kuwanon-L; multiple target binding

PMID:
27992102
DOI:
10.1002/cbic.201600592
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Wiley
Loading ...
Support Center